Met-kinase-in-2

MET kinase-IN-2 is a potent and selective MET inhibitor with an IC50 of 7.4 nM. It demonstrates oral bioavailability and has shown antitumor activity in research models, supporting its use in studying MET-driven cancers in both in vitro and in vivo experimental settings.